Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03543813
Title PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors CytomX Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR | ESP


No variant requirements are available.